Boothbay Fund Management, LLC Cytokinetics Inc Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$51.22 - $60.16 $783,666 - $920,448
15,300 New
15,300 $807,000
Q4 2023

Feb 14, 2024
BUY
$26.88 - $83.49 $4.05 Million - $12.6 Million
150,600 Added 363.77%
192,000 $16 Million
Q3 2023

Nov 14, 2023
BUY
$29.46 - $36.61 $1.22 Million - $1.52 Million
41,400 New
41,400 $1.22 Million
Q3 2022

Nov 14, 2022
BUY
$38.54 - $54.52 $4.02 Million - $5.69 Million
104,400 New
104,400 $5.06 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.9B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email